Skip to main content
Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years.
Statin Initiation and Dementia Incidence in a Large Health Care System From 1997 to 2020: A Target Trial Emulation Study.
Treatment Patterns and Disease Burden of Juvenile Myasthenia Gravis in the United States: A Cohort Study Using Health Care Claims Databases.
Epigenetic Aging in Pediatric-Onset Multiple Sclerosis.
Understanding the Incidence, Prevalence, Characteristics, and Healthcare Resource Utilization for Patients With Dravet and Lennox-Gastaut Syndromes (P8-11.003).
Safety and Effectiveness of Fenfluramine for the Treatment of Seizures in Lennox-Gastaut Syndrome: Results From the Final Analysis of an Open-Label Extension Study (P8-9.002).
Real-World Use of Fenfluramine for Dravet Syndrome: a Retrospective Cohort Study Using a National Pharmacy Database (P12-9.002).
Impact of Fenfluramine on Convulsive Seizure Frequency in Dose-Capped Patients With Dravet Syndrome (P8-9.015).
A Stratified Analysis of Efficacy and Safety of Fenfluramine in Patients With Dravet Syndrome (P8-9.014).
A Retrospective Claims Study Evaluating Mortality in Patients With Lennox-Gastaut or Dravet Syndromes in the United States (P8-11.004).